Dial

Dial Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing improved formulations of widely used medications to enhance safety and efficacy. The company's lead product candidate is a novel, liquid-based formulation of aspirin designed to reduce the gastrointestinal side effects typically associated with traditional aspirin therapy. By utilizing a proprietary lipid-based delivery system, Dial aims to provide the cardiovascular and analgesic benefits of aspirin while minimizing the risk of stomach ulcers and bleeding. The company is currently advancing its pipeline through late-stage clinical trials to address significant unmet needs in pain management and cardiovascular health.